miércoles, 4 de diciembre de 2019

4 questions key to making sense of new data on Biogen’s Alzheimer’s drug

4 questions key to making sense of new data on Biogen’s Alzheimer’s drug

Morning Rounds

Shraddha Chakradhar

What to read around the web today

  • Meet Jeff Morgan, STAT 2019 Wunderkind. STAT
  • China’s CRISPR babies: Read exclusive excerpts from the unseen original research. MIT Technology Review
  • The class of 2000 'could have been anything.' The New York Times
  • 4 questions key to making sense of new data on Biogen’s resurrected Alzheimer’s drug. STAT Plus
  • EMS crews brought patients to the hospital with misplaced breathing tubes. None of them survived. The Public's Radio/ProPublica

No hay comentarios: